一种新的单剂量药物Acozibolayer在治疗睡眠疾病方面获得了欧盟的批准。 A new single-dose drug, acoziborole, has gained EU approval for treating sleeping sickness.

Acoziboplole Winthrop是针对最常见的昏睡病的一种三片的单剂量治疗,从欧洲药品署的CHMP得到了积极的意见。 Acoziborole Winthrop, a three-tablet, single-dose treatment for the most common form of sleeping sickness, has received a positive opinion from the European Medicines Agency's CHMP. 该药物由DNDi和Sanofi开发,在治疗非洲锥虫病方面取得了显著进步,有可能改善受影响地区的获得和结果。 Developed by DNDi and Sanofi, the drug offers a significant advancement in treating African trypanosomiasis, potentially improving access and outcomes in affected regions.